Refactor Capital. Rethink. industries. Refactor. the world. Our companies aim to solve fundamental human problems. We invest in seed-stage companies using software and technology to upend and radically improve traditionally regulated industries, namely biology and health. This is refactoring at its essence—creating more efficient, accessible
Tempest is an evidence-based digital recovery program. Ophelia provides medication & support for quitting opioids. Vital is modern emergency department software. Iaso helps scale telemedicine effectively. Enzyme is FDA compliance and quality systems as a service. Avail digitizes physical presence in medical procedures.